22 high-performance-quantum-computing Postdoctoral positions at University of London in United Kingdom
Sort by
Refine Your Search
-
project on Addressing socio-technical limitations of Large Language Models (LLMs), particularly for medical and social computing (https://adsolve.github.io/ ). The role involves developing methods
-
and development of the research programme. The successful candidate will undertake the research investigations under the supervision of the Principal Investigators and in collaboration with other
-
will plan and conduct experiments, generate high-quality data, prepare publications, make presentations and help supervise associated PhD students. The successful candidates will join large, supportive
-
and statistical modelling, statistical image analysis and computer vision, chemometrics, biophysics, bioengineering. Preference will be given to candidates with a demonstrated experience in applying
-
About the Role We are looking for a Postdoctoral Research Assistant to work with Dr Chema Martin on a Human Frontiers Science Program Research Grant project entitled “Evolutionary Biophysics
-
, Spain and Norway. The project runs until early 2028 and investigates the potential role of performance-based arts in understanding how coastal communities learn about and respond to ecological crises
-
multidisciplinary School, we are well known for our pioneering research and pride ourselves on our world-class projects. We are equal first in the UK for the impact of our Computer Science research, and second in
-
nanotechnology and electrical sensing investigations (with 2D nanostructures), with an established track record of success in high-quality original research. Applicants should have a solid grounding in different
-
or biomechanics. The researcher should be able to demonstrate the ability to publish in high quality scientific journals. A strong knowledge of using the ABAQUS simulation software package within
-
of murine models of high-grade lymphoma with the aim of providing pre-clinical evidence to support the development of metabolic inhibitors as novel treatments for lymphoma, alone or in combination with